Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 83Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 22care4 ApS

02 1A.F.O.M. DIPENDENZE Srl

03 1ACTAVIS GROUP HF

04 3Actavis Group hf.

05 1Bioglan AB

06 3Cross Pharma AB

07 1Medartuum AB

08 3Orifarm AB

09 1Teva Pharma AG

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

disulfiram

Brand Name : Antabuse

Dosage Form : EFFERVESCENT TABLET

Dosage Strength : 200 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

disulfiram

Brand Name : Antabuse

Dosage Form : EFFERVESCENT TABLET

Dosage Strength : 400 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

disulfiram

Brand Name : Antabuse

Dosage Form : EFFERVESCENT TABLET

Dosage Strength : 400 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

disulfiram

Brand Name : Antabuse

Dosage Form : EFFERVESCENT TABLET

Dosage Strength : 400 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

05

2care4 ApS

Country
2024 ACI Convention
Not Confirmed
arrow

2care4 ApS

Country
arrow
2024 ACI Convention
Not Confirmed

disulfiram

Brand Name : Antabuse

Dosage Form : EFFERVESCENT TABLET

Dosage Strength : 400 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

06

Cross Pharma AB

Country
2024 ACI Convention
Not Confirmed
arrow

Cross Pharma AB

Country
arrow
2024 ACI Convention
Not Confirmed

disulfiram

Brand Name : Antabuse

Dosage Form : EFFERVESCENT TABLET

Dosage Strength : 400 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

07

2care4 ApS

Country
2024 ACI Convention
Not Confirmed
arrow

2care4 ApS

Country
arrow
2024 ACI Convention
Not Confirmed

disulfiram

Brand Name : Antabuse

Dosage Form : EFFERVESCENT TABLET

Dosage Strength : 400 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

08

Medartuum AB

Country
2024 ACI Convention
Not Confirmed
arrow

Medartuum AB

Country
arrow
2024 ACI Convention
Not Confirmed

disulfiram

Brand Name : Antabuse

Dosage Form : EFFERVESCENT TABLET

Dosage Strength : 400 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

09

Cross Pharma AB

Country
2024 ACI Convention
Not Confirmed
arrow

Cross Pharma AB

Country
arrow
2024 ACI Convention
Not Confirmed

disulfiram

Brand Name : Antabuse

Dosage Form : EFFERVESCENT TABLET

Dosage Strength : 400 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

10

Cross Pharma AB

Country
2024 ACI Convention
Not Confirmed
arrow

Cross Pharma AB

Country
arrow
2024 ACI Convention
Not Confirmed

disulfiram

Brand Name : Antabuse

Dosage Form : EFFERVESCENT TABLET

Dosage Strength : 400 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank